Exhibit 99.1

     
(AAIPHARMA LOGO)
  News
Release

2320 Scientific Park Drive
Wilmington, NC 28405
Nasdaq: AAII

Contact:
Matthew Czajkowski
Executive Vice President and CFO
910-254-7838

aaiPharma Announces Delay in 10-K Filing and
Non-compliance with Nasdaq Listing Requirement

Other Matters Reported in Filings with SEC

Wilmington, N.C., March 16, 2005

- aaiPharma Inc. (NASDAQ: AAII) today announced that the Company has filed a Notification of Late Filing Report on Form 12b-25 with the Securities and Exchange Commission reporting that it will not file its 2004 Annual Report on Form 10-K today, the deadline for filing that report. The Company is striving to file its 2004 Form 10-K as soon as possible. However, the Company did not represent in its Form 12b-25 filing that it would be able to file its 2004 Form 10-K by March 31, which is required by SEC rules to obtain a 15-day extension of the filing deadline, because the Company believes it will not be able to file its 2004 Form 10-K by that date.

As a result of its failure to file the 2004 Form 10-K by March 16, 2005, the Company is no longer in compliance with conditions for the continued listing of the Company’s common stock on the Nasdaq Stock Market under Nasdaq Marketplace Rule 4310(c)(14) and under the terms of the June 2004 decision of a Nasdaq Listing Qualifications Panel that had permitted continued listing of the Company’s common stock. The Company has notified Nasdaq of its violation of these conditions and has requested that its common stock be permitted to continue to be listed on the Nasdaq Stock Market if the Company files its 2004 Form 10-K by April 30, 2005. April 30, 2005 is the extended deadline that would have been applicable to the Company’s filing of management’s assessment of internal control over financial reporting and the related attestation report of its independent registered public accountants under an SEC order issued in November 2004 and applicable to smaller issuers like the Company if the Company were to have filed its 2004 Form 10-K by March 16, 2005. As indicated in the Company’s Notification of Late Filing, delay in the completion of management’s assessment of internal control is a critical reason preventing the Company from timely filing its 2004 Form 10-K. Notwithstanding the request to Nasdaq, Nasdaq may determine to immediately suspend trading and cease listing of the Company’s common stock.

For information about other significant developments and issues that have affected and are affecting the Company, including preliminary 2004 financial results, the status of the Company’s exploration of potential asset sales, liquidity issues, the need for a financial restructuring, and identified material weaknesses in internal control over financial reporting, please refer to the Company’s Notification of Late Filing Report on Form 12b-25 and Current Report on Form 8-K filed with the SEC on March 16, 2005.

 


The following information was filed by Aaipharma Inc on Wednesday, March 16, 2005 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-K Annual Report statement of earnings and operation as management may choose to highlight particular information in the press release.

View differences made from one year to another to evaluate Aaipharma Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Aaipharma Inc.

Continue

Never Miss A New SEC Filing Again


Real-Time SEC Filing Notifications
Screenshot taken from Gmail for a new 10-K Annual Report
Last10K.com Member Feature

Receive an e-mail as soon as a company files an Annual Report, Quarterly Report or has new 8-K corporate news.

Continue

We Highlighted This SEC Filing For You


SEC Filing Sentiment Analysis - Bullish, Bearish, Neutral
Screenshot taken from Wynn's 2018 10-K Annual Report
Last10K.com Member Feature

Read positive and negative remarks made by management in their entirety without having to find them in a 10-K/Q.

Continue

Widen Your SEC Filing Reading Experience


Increased Reading Area for SEC Filings
Screenshot taken from Adobe Inc.'s 10-Q Quarterly Report
Last10K.com Member Feature

Remove data columns and navigations in order to see much more filing content and tables in one view

Continue

Uncover Actionable Information Inside SEC Filings


SEC Filing Disclosures
Screenshot taken from Lumber Liquidators 10-K Annual Report
Last10K.com Member Feature

Read both hidden opportunities and early signs of potential problems without having to find them in a 10-K/Q

Continue

Adobe PDF, Microsoft Word and Excel Downloads


Download Annual and Quarterly Reports as PDF, Word and Excel Documents
Screenshots of actual 10-K and 10-Q SEC Filings in PDF, Word and Excel formats
Last10K.com Member Feature

Export Annual and Quarterly Reports to Adobe PDF, Microsoft Word and Excel for offline viewing, annotations and analysis

Continue

FREE Financial Statements


Download Annual and Quarterly Reports as PDF, Word and Excel Documents
Screenshot of actual balance sheet from company 10-K Annual Report
Last10K.com Member Feature

Get one-click access to balance sheets, income, operations and cash flow statements without having to find them in Annual and Quarterly Reports

Continue for FREE

Intrinsic Value Calculator


Intrinsic Value Calculator
Screenshot of intrinsic value for AT&T (2019)
Last10K.com Member Feature

Our Intrinsic Value calculator estimates what an entire company is worth using up to 10 years of financial ratios to determine if a stock is overvalued or not

Continue

Financial Stability Report


Financial Stability Report
Screenshot of financial stability report for Coco-Cola (2019)
Last10K.com Member Feature

Our Financial Stability reports uses up to 10 years of financial ratios to determine the health of a company's EPS, Dividends, Book Value, Return on Equity, Current Ratio and Debt-to-Equity

Continue

Get a Better Picture of a Company's Performance


Financial Ratios
Available Financial Ratios
Last10K.com Member Feature

See how over 70 Growth, Profitability and Financial Ratios perform over 10 Years

Continue

Log in with your credentials

or    

Forgot your details?

Create Account